Brilinta May Offer Protection Long After MI

January 14, 2015 7:40 PM

7 0

Brilinta May Offer Protection Long After MI

Top-line results from PEGASUS show secondary prevention benefits beyond 1 year.

Ticagrelor (Brilinta) reduced major cardiovascular events when given to patients 1 to 3 years out from myocardial infarction (MI), drugmaker AstraZeneca announced.

Also read: Mourning and vigilance in San Bernardino 1 year after terror attack

Read more

To category page

Loading...